Resources, guidance and updates from the GDP community.
2026 M&DP Conference
Question 2: “Will you be challenging the assumption that Licence Holders are competent by default if their RP is on the licence and providing a definition of what competence actually looks like in practice?” Victoria Emerton (VE) – Making and...
2026 M&DP Conference
Question 1: Why is the focus on the competence of a Responsible Person a critical obligation of the Licence Holder and so timely? Victoria Emerton (VE) – Making and Distributing Pharmaceuticals: “Paradigm Shift Group and the UK GDP Association...
Guidance
In today’s pharmaceutical landscape, GDP compliance is no longer a back-office responsibility - it’s a make-or-break factor that can elevate or collapse your distribution credibility. UK wholesalers, distributors, and pharmaceutical outlets are...
Latest News
The pharmaceutical industry operates within a highly regulated landscape, where the integrity and quality of medicinal products are paramount. Good Distribution Practice (GDP) guidelines are the cornerstone of this commitment, ensuring that...
Guidance
The pharmaceutical industry, while dedicated to healing and well-being, has a significant environmental footprint. From manufacturing to distribution, the processes involved consume considerable energy and resources. As sustainability becomes an...
2025 Conferences
In the complex and highly regulated world of pharmaceutical distribution, ensuring the integrity of the supply chain is paramount. Every link, from the initial sourcing of medicinal products to their final delivery, must be robust, reliable, and...
As the pharmaceutical distribution landscape continues to evolve, ensuring compliance with Good Distribution Practice (GDP) remains paramount for UK wholesalers. With increasing regulatory scrutiny and the complexities of modern supply chains,...
Guidance
The global distribution of temperature-sensitive pharmaceuticals presents significant logistical and regulatory challenges. Maintaining product integrity and supply chain security requires a robust cold chain and robust risk assessed...
Information
Redefining Pharmaceutical Logistics In the high-stakes world of pharmaceutical logistics, where time and precision are crucial, CoolReach Healthcare Logistics stands out as an innovative player. Focusing on clinical trials and biopharmaceutical...
Guidance
Unless you’re a global sized pharma company with a beautifully resourced quality department, route risk assessments can be a challenge. When I say “challenge”, I mean in terms of time consuming, and the understanding of the supply chain required to...
Guidance
Export is defined as to allow GB goods to leave the customs territory. It is the responsibility of the exported Consignor to ensure that. Medicinal products remain in the legal supply chain. Export paperwork is completed correctly. Proof of export...
Guidance
‘Quality’ has become a more embracing and holistic notion concerning itself not only with the distribution of pharmaceutical products but also with those processes that may impact on the distribution process itself. As the pharmaceutical industry...
Join the UK GDP Association to access exclusive member-only articles, early event access, and professional development resources.